Emergent BioSolutions reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
Akebia Therapeutics 0 0 Mar/2025
Coherus Biosciences 0 0 Mar/2025
Emergent BioSolutions 0 0 Mar/2025
Glaxosmithkline GBP 4.47 0.32 Dec/2025
Heron Therapeutics 0 0 Mar/2025
Lexicon Pharmaceuticals 0 0 Mar/2025
Lonza 0.74 0.04 Dec/2025
Merck 2.76 0.36 Mar/2026
Nektar Therapeutics 0 0 Mar/2025
Pfizer 7.08 0.72 Jun/2026
Sanofi 5.49 0.51 Jun/2026
Vanda Pharmaceuticals 0 0 Mar/2025